Investigative Ophthalmology & Visual Science
Investigative Ophthalmology & Visual Science (Invest. Ophthalmol. Vis. Sci., known as IOVS) is published by the Association for Research in Vision and Ophthalmology itself. Founded in 1962 as Investigative Ophthalmology and under its present name since 1977, it covers all directions of ophthalmology and vision science, has been fully gold open access since 2016, is online only, and had a 2025 impact factor of 5.5.《眼科与视觉科学研究》（Investigative Ophthalmology & Visual Science''''，缩写 Invest. Ophthalmol. Vis. Sci.，通称 IOVS）是视觉与眼科学研究协会自行出版的刊物，1962 年创刊（创刊刊名为Investigative Ophthalmology''），1977 年起用现名。该刊覆盖眼科学与视觉科学的全部方向，2016 年起为完全金色开放获取，现为纯在线出版，二〇二五年影响因子为 5.5。
Scope
The journal's editorial stance is that it covers all experimental directions in vision and eye research: its scope maps onto the association's thirteen scientific sections, admitting everything from molecular mechanism to clinical and epidemiological study. Coverage includes:本刊的取稿立场是「覆盖视觉与眼科学的全部实验方向」：收录范围与该会十三个学科分部一一对应，从分子机制到临床与流行病学研究均可发表。收文方向包括：
- Retina and retinal cell biology: retinal pigment epithelium and photoreceptors, mechanisms of retinal degeneration, retinal cell biology, and gene and cell therapy.视网膜与视网膜细胞生物学： 视网膜色素上皮与光感受器、视网膜变性机制、视网膜细胞生物学、基因与细胞治疗。
- Cornea, lens and cataract: corneal epithelium and stroma, corneal endothelium and transplantation, lens transparency and cataract formation, and ocular surface disease.角膜、晶状体与白内障： 角膜上皮与基质、角膜内皮与移植、晶状体透明性与白内障形成、眼表疾病。
- Glaucoma and the optic nerve: intraocular pressure and aqueous dynamics, neuroprotection, mechanisms and treatment of glaucoma, and optic nerve regeneration.青光眼与视神经： 眼压与房水动力学、视神经保护、青光眼的机制与治疗、视神经再生。
- Visual neuroscience and visual function: visual pathways and central processing, visual psychophysics and physiological optics, eye movements, strabismus and amblyopia, and visual development and plasticity.视觉神经科学与视功能： 视觉通路与中枢处理、视觉心理物理学与生理光学、眼动斜视与弱视、视觉发育与可塑性。
- Immunology, microbiology and molecular biology: ocular immunity and inflammation, ocular infection and microbiology, biochemistry and molecular biology, and anatomy and pathology.免疫、微生物与分子生物学： 眼部免疫与炎症、眼感染与微生物、生化与分子生物学、解剖与病理。
- Clinical and epidemiological research: clinical trials and outcomes research, epidemiology and screening, imaging and functional testing, and artificial intelligence-assisted diagnosis.临床与流行病学研究： 临床试验与结局研究、流行病学与筛查、影像与功能检测、人工智能辅助诊断。
The journal has been fully gold open access since January 2016, with authors retaining copyright under a Creative Commons attribution or attribution-noncommercial-noderivatives licence. The publisher publishes neither review speed nor acceptance rate.本刊自 2016 年 1 月起为完全金色开放获取，作者保留版权，采用知识共享署名或署名—非商业性—禁止演绎许可；出版方未公布审稿时效与录用比例。[1]
History
- Founding and renaming (1962, 1977): the journal was founded in 1962 as Investigative Ophthalmology with Bernard Becker as founding executive editor. It took its present name in 1977, from when the association's annual meeting abstracts were published as an issue of the journal, and it entered Index Medicus and MEDLINE in the same year. The founding year of 1962 differs from the year the present name took effect, 1977.创刊与改名（1962年、1977年）： 1962 年创刊，创刊刊名为《眼科学研究》，首任主编为（Bernard Becker）；1977 年改用现名并起将该会年会摘要作为正刊的一期出版，同年被 Index Medicus 与 MEDLINE 收录；创刊年 1962 年与现名启用年 1977 年不同。[2]
- Digitisation and format: the journal went online in July 1999, completed retrospective digitisation of back issues in 2005 and became online only in 2010, with the last print issue in 2009.数字化与出版形态： 1999 年 7 月本刊上网，2005 年完成过刊回溯数字化，2010 年转为纯在线出版（最后一期印刷版为 2009 年）。
- Open access transition (2016): in January 2016 the journal ended subscriptions and became fully gold open access, with authors retaining copyright under Creative Commons licences.开放获取转型（2016年）： 2016 年 1 月本刊终止订阅制，转为全额金色开放获取，作者保留版权，采用知识共享许可。
- Metrics and indexing: the 2025 CiteScore is 5.3, with an SJR of 1.274 and an SNIP of 1.323, from Scopus指标与收录： 2025 年引用分数 5.3、（SJR）1.274、（SNIP）1.323（Scopus 官方）；2025 年期刊引证报告影响因子 5.5；本刊被 MEDLINE、科学引文索引扩展版、Scopus 与 DOAJ 收录。 the 2025 Journal Citation Reports impact factor is 5.5. The journal is indexed in MEDLINE, the Science Citation Index Expanded, Scopus and DOAJ.[2]
Editors
The editor is elected by the association for a fixed term. The present editor comes from the Medical College of Wisconsin, took up the post in January 2023 and serves to 2027本刊主编由该会通过选举产生，任期固定；现任主编来自威斯康星医学院，2023 年 1 月就任，任期至 2027 年，下任人选已由 2026 年选举产生。 a successor has been chosen in the 2026 election.[3]
- Present editor-in-chief: Joseph Carroll of the Medical College of Wisconsin took up the post in January 2023 and serves to 2027. The incoming editor is Lisa Ostrin, who begins a transition in June 2026 and holds the formal term from 1 January 2028 to 31 December 2032.现任主编： （Joseph Carroll）供职于威斯康星医学院，2023 年 1 月就任，任期至 2027 年；下任为（Lisa Ostrin），2026 年 6 月起过渡，正式任期自 2028 年 1 月 1 日至 2032 年 12 月 31 日。
- Founding and past editors: the founding editor was Bernard Becker, serving from 1962 to 1972. The tenure years of the remaining editors are not published online by the association in a verifiable full list and are recorded here as not published首任与历任： 首任主编为（Bernard Becker），1962 年至 1972 年在任；其余历任主编的任期年份该会官网未在线公布可核验的完整名单，本稿按未公布处理，不采用镜像站数据。 data from mirror sites is not used.
- Role in the field: as the association's official journal, it binds the annual meeting abstracts and research articles into the same volume, making it the main formal channel for researchers beyond conference presentation. Since the move to gold open access, accessibility of its content in low-income countries has improved markedly.学科角色： 作为该会的官方刊物，本刊把年会摘要与研究论文编入同一卷期，是研究者在会议报告之外正式发表的主要渠道；转为金色开放获取后，其内容在低收入国家的可及性显著提高。